메뉴 건너뛰기




Volumn 117, Issue 5, 2008, Pages 367-369

Long-term assessment of oxcarbazepine in a naturalistic setting: A retrospective study

Author keywords

Antiepileptics; Epilepsy; Oxcarbazepine; Retention rate

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PRIMIDONE; TIAGABINE; VALPROIC ACID; VIGABATRIN;

EID: 41849143740     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2007.00951.x     Document Type: Article
Times cited : (4)

References (12)
  • 1
    • 0038679502 scopus 로고    scopus 로고
    • Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy
    • Kwan P, Brodie MJ. Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy. Neurology 2003 60 (Suppl. 4 S2 12.
    • (2003) Neurology , vol.60 , Issue.4
    • Kwan, P.1    Brodie, M.J.2
  • 2
    • 33746124186 scopus 로고    scopus 로고
    • ILAE treatment guidelines: Evidence based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
    • Glauser T, Ben-Menachem E, Bourgeois B et al. ILAE treatment guidelines: evidence based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006 47 : 1094 120.
    • (2006) Epilepsia , vol.47 , pp. 1094-120
    • Glauser, T.1    Ben-Menachem, E.2    Bourgeois, B.3
  • 3
    • 0031873690 scopus 로고    scopus 로고
    • Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy
    • Ilae Commission on Antiepileptic Drugs.
    • Ilae Commission on Antiepileptic Drugs. Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy. Epilepsia 1998 39 : 799 803.
    • (1998) Epilepsia , vol.39 , pp. 799-803
  • 4
    • 0343247768 scopus 로고    scopus 로고
    • A double-blind controlled clinical trial: Oxcarbazepine versus valproate in adults with newly diagnosed epilepsy
    • Christe W, Kramer G, Vigonius U et al. A double-blind controlled clinical trial: oxcarbazepine versus valproate in adults with newly diagnosed epilepsy. Epilepsy Res 1997 26 : 451 60.
    • (1997) Epilepsy Res , vol.26 , pp. 451-60
    • Christe, W.1    Kramer, G.2    Vigonius, U.3
  • 5
    • 0030796901 scopus 로고    scopus 로고
    • A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy
    • Guerreiro MM, Vigonius U, Pohlmann H et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res 1997 27 : 205 13.
    • (1997) Epilepsy Res , vol.27 , pp. 205-13
    • Guerreiro, M.M.1    Vigonius, U.2    Pohlmann, H.3
  • 6
    • 0030805745 scopus 로고    scopus 로고
    • A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy
    • Bill PA, Vigonius U, Pohlmann H et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Res 1997 27 : 195 204.
    • (1997) Epilepsy Res , vol.27 , pp. 195-204
    • Bill, P.A.1    Vigonius, U.2    Pohlmann, H.3
  • 7
    • 0034892505 scopus 로고    scopus 로고
    • Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: A systematic review
    • Marson AG, Hutton JL, Leach JP et al. Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review. Epilepsy Res 2001 46 : 259 70.
    • (2001) Epilepsy Res , vol.46 , pp. 259-70
    • Marson, A.G.1    Hutton, J.L.2    Leach, J.P.3
  • 8
    • 0034535858 scopus 로고    scopus 로고
    • Oxcarbazepine: Placebo controlled, dose-ranging trial in refractory partial epilepsy
    • Barcs G, Walker E, Elger CE et al. Oxcarbazepine: placebo controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia 2000 41 : 1597 607.
    • (2000) Epilepsia , vol.41 , pp. 1597-607
    • Barcs, G.1    Walker, E.2    Elger, C.E.3
  • 9
    • 18844471793 scopus 로고    scopus 로고
    • Adjunctive therapy with oxcarbazepine in children with partial seizures. the Oxcarbazepine Pediatric Study Group
    • Glauser TA, Nigro M, Sachdeo R et al. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group. Neurology 2000 54 : 2237 44.
    • (2000) Neurology , vol.54 , pp. 2237-44
    • Glauser, T.A.1    Nigro, M.2    Sachdeo, R.3
  • 10
    • 12144267359 scopus 로고    scopus 로고
    • Retention rate of oxcarbazepine monotherapy in an unselected population of adult epileptics
    • Rainesalo S, Peltola J, Auvinen A, Keranen T. Retention rate of oxcarbazepine monotherapy in an unselected population of adult epileptics. Seizure 2005 14 : 72 4.
    • (2005) Seizure , vol.14 , pp. 72-4
    • Rainesalo, S.1    Peltola, J.2    Auvinen, A.3    Keranen, T.4
  • 11
    • 33746924499 scopus 로고    scopus 로고
    • Comparison of the efficacy and tolerability of new antiepileptic drugs: What can we learn from long-term studies?
    • Zaccara G, Messori A, Cincotta M, Burchini G. Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies? Acta Neurol Scand 2006 114 : 157 68.
    • (2006) Acta Neurol Scand , vol.114 , pp. 157-68
    • Zaccara, G.1    Messori, A.2    Cincotta, M.3    Burchini, G.4
  • 12
    • 15344351223 scopus 로고    scopus 로고
    • What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?
    • Schmidt D, Elger CE. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs? Epilepsy & Behavior 2004 5 : 627 35.
    • (2004) Epilepsy & Behavior , vol.5 , pp. 627-35
    • Schmidt, D.1    Elger, C.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.